Structures by: Turgunov K. K.
Total: 14
1-(2-hydroxyphenyl)-2-(2-hydroxyethyl)-6,7-dimethoxy-1,2,3,4- tetrahydroisoquinoline
C19H23NO4
Acta Crystallographica Section C (2016) 72, 8
a=7.4320(15)Å b=9.962(2)Å c=11.373(2)Å
α=85.63(3)° β=85.34(3)° γ=81.32(3)°
2-(2-Hydroxyethyl)-1-(2-hydroxyphenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline
C19H23NO4
Acta Crystallographica Section C (2016) 72, 8
a=7.429(2)Å b=14.535(4)Å c=15.675(4)Å
α=97.575(5)° β=98.902(5)° γ=92.280(5)°
Anagyrine perchlorate
C15H21N2O,ClO4
Acta Crystallographica Section E (2015) 71, 5 o343-o344
a=7.3550(3)Å b=32.9820(10)Å c=12.8849(4)Å
α=90.00° β=90.709(3)° γ=90.00°
2,3-Dimethoxy-5,6,7,8,13,13a-hexahydro-6a,8-diazaindeno[2,1-<i>b</i>]phenanthrene methanol monosolvate
C21H22N2O2,C1H4O1
Acta Crystallographica Section E (2015) 71, 8 o574-o575
a=7.6080(3)Å b=11.8061(5)Å c=12.3327(5)Å
α=65.242(4)° β=73.956(4)° γ=75.724(4)°
Α-Aminomethylidene-2,3-pentamethylenepyrido[2,3-<i>d</i>]pyrimidin-4-one
C13H14N4O
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 10 1497-1500
a=8.7260(7)Å b=15.236(3)Å c=8.6642(7)Å
α=90° β=98.046(8)° γ=90°
2,3-gexamethylene-3,4-dihydroquinazolin-4-one
C14H16N2O
Acta Crystallographica Section E (2009) 65, 8 o1776
a=9.5490(19)Å b=10.584(2)Å c=11.693(2)Å
α=90.00° β=90.00° γ=90.00°
11-(2-Oxopyrrolidin-1-ylmethyl)-1,2,3,4,5,6,11,11a-octahydropyrido[2,1-<i>b</i>]quinazolin-6-one dihydrate
C17H21N3O2,2(H2O)
Acta Crystallographica Section E (2010) 66, 4 o890
a=14.794(3)Å b=7.6720(15)Å c=15.593(3)Å
α=90.00° β=104.48(3)° γ=90.00°
3-Benzyl-6-(2-chlorobenzoyl)-1,3-benzoxazol-2(3<i>H</i>)-one
C21H14ClNO3
Acta Crystallographica Section E (2010) 66, 12 o3203
a=13.391(7)Å b=7.317(6)Å c=18.611(9)Å
α=90.00° β=109.72(4)° γ=90.00°
5,7,3'-Trihydroxy-6,4',5'-trimethoxyflavone
C18H16O8
Acta Crystallographica Section E (2013) 69, 4 o578
a=11.5837(6)Å b=4.4677(3)Å c=15.5521(8)Å
α=90.00° β=103.310(6)° γ=90.00°
(4-Nitrophenyl)(1,2,3,9-tetrahydropyrrolo[2,1-<i>b</i>]quinazolin-3- yl)methanol monohydrate
C18H17N3O3,H2O
Acta Crystallographica Section E (2011) 67, 7 o1680
a=6.2459(7)Å b=11.4629(11)Å c=11.8400(13)Å
α=91.932(8)° β=95.589(9)° γ=104.747(9)°
Poly[di-μ-chlorido-μ-(1,2,3,9-tetrahydropyrrolo[2,1-<i>b</i>]quinazolin- 9-one-κ^2^<i>N</i>:<i>O</i>)-mercury(II)]
C11H10Cl2HgN2O
Acta Crystallographica Section E (2011) 67, 7 m953-m954
a=7.7275(11)Å b=9.4705(13)Å c=16.729(2)Å
α=90.00° β=101.416(2)° γ=90.00°
2,3-Dihydropyrrolo[2,1-<i>b</i>]quinazoline-9(1<i>H</i>)-thione
C11H10N2S
Acta Crystallographica Section E (2012) 68, 6 o1746
a=26.2060(10)Å b=26.2060(10)Å c=7.441(2)Å
α=90.00° β=90.00° γ=120.00°
[2-(3,4-Dimethoxyphenyl)ethyl](3-{<i>N</i>-[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl}propyl)azanium chloride dihydrate
C24H35N2O5,Cl,2(H2O)
Acta Crystallographica Section E (2014) 70, 2 o232
a=21.977(3)Å b=12.2295(10)Å c=10.2217(9)Å
α=90.00° β=93.490(9)° γ=90.00°
Diaquadichloridobis[quinazolin-4(1<i>H</i>)-one-κ<i>N</i>^3^]nickel(II)
C16H16Cl2N4NiO4
Acta Crystallographica Section E (2012) 68, 6 m724
a=6.7800(5)Å b=18.741(2)Å c=6.6106(5)Å
α=90.00° β=93.782(8)° γ=90.00°